ACM
WST icon

Aster Capital Management’s West Pharmaceutical WST Stock Holding History

Aster Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.63K Buy
+43
New +$10.7K ﹤0.01% 631
2025
Q4 		– Sell
-1,233
Closed -$323K – 1463
2025
Q3 		$323K Buy
1,233
+1,178
+2,142% +$286K 0.16% 175
2025
Q2 		$12K Buy
+55
New +$11.8K ﹤0.01% 767
2024
Q4 		– Sell
-84
Closed -$25.2K – 1569
2024
Q3 		$25.2K Buy
+84
New +$25.7K 0.01% 645

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aster Capital Management's WST Position: Q1 2026 in Review

Aster Capital Management opened a new position in West Pharmaceutical (WST) in Q1 2026: 43 shares worth $9.63K. The stake represents ﹤0.01% of the portfolio and ranks #631 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in WST as recently as Q3 2025.

Aster Capital Management first reported a position in WST in Q3 2024 and has held it in 4 quarters since. The position peaked at $323K in Q3 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Aster Capital Management held 43 shares of West Pharmaceutical worth $9.63K as of Q1 2026.
  • West Pharmaceutical was a new Aster Capital Management position in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #631 holding.
  • Aster Capital Management first reported a position in West Pharmaceutical in Q3 2024 and has held it in 4 quarters since.
  • Aster Capital Management's West Pharmaceutical position peaked at $323K in Q3 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.